about
Generation of knockout rabbits using transcription activator-like effector nucleasesMesenchymal stromal cell therapy in liver disease: opportunities and lessons to be learnt?Stem cells for liver regenerationDysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptakeLiraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialNon-alcoholic fatty liver disease and liver transplantation.Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases.Development of an invasively monitored porcine model of acetaminophen-induced acute liver failure.Changes in human hepatic metabolism in steatosis and cirrhosis.Pathogenesis of non-alcoholic fatty liver disease.Combined use of N-acetylcysteine and Liberase improves the viability and metabolic function of human hepatocytes isolated from human liverComparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism.Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experienceSphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.Loss of 5α-reductase type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice.Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study.Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.UK experience of liver transplantation for erythropoietic protoporphyria.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stemHepatic oval cells: helping redefine a paradigm in stem cell biology.Potential of hematopoietic stem cell therapy in hepatology: a critical review.Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol.Hematopoietic stem cell trafficking in liver injury.Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis.Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling.CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanismYet another role for mesenchmyal stem cells?Critical review of clinical trials of bone marrow stem cells in liver disease.Severe asymptomatic non-alcoholic fatty liver disease in routine diabetes care; a multi-disciplinary team approach to diagnosis and management.Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.Current therapeutic strategies in non-alcoholic fatty liver disease.Use of hepatocyte and stem cells for treatment of post-resectional liver failure: are we there yet?New horizons for stem cell therapy in liver disease.Bone marrow stem cell therapy for liver disease.Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.
P50
Q22001128-EE4C3862-5977-4662-9AC4-9EF02036BEA3Q26796475-79724778-080A-41F6-8CCE-E22077C591DFQ26823688-DD9542C2-D512-4880-A2E1-432549AB01FEQ28250220-4DBB6AE5-5CFA-4DD2-8833-76662E086E98Q28661700-61958B27-D1F8-4AE9-B11F-28231E1EDB28Q30251746-98402EF1-7857-4805-9BD4-600515AA8752Q30577903-4BCC5ED6-83C1-4737-8D1F-9257A1264563Q30847903-9671AA16-6770-4467-B8B0-2C9FF13F7BF0Q33547724-43C5A229-0AEC-43F0-B226-1BEEB171C936Q33599515-23E11180-E734-48B0-94A9-36FADE6FA811Q33606303-491608E3-942C-4638-9240-460991302FE2Q33642195-103382FE-B5BD-4762-8EA8-AD040643E5E5Q33728023-0F4C9410-598B-419A-A9C7-81E338916598Q33806641-C1F8D472-C2F5-486E-8916-4472D02A47D7Q33867498-C8E24EFD-A9AF-4B75-B90C-ADB272252F52Q33907049-83BD310A-287F-4930-9402-4E71CC1C218FQ34169832-CE480699-2E4A-43AB-9FE4-6754265E4ECFQ34310464-59AE06F3-9FED-4DCF-B568-3BF5A3F25802Q34316501-210E82C4-BCBF-41DA-ABD2-14BA178B52F1Q34356052-20E8F15F-3DF4-417A-86F8-3EC776AEB611Q34830398-1D6B9AA0-EF9E-48EB-B1AC-797BD5C579A6Q35004685-80487488-01BF-48CB-82A3-B251092AC1EAQ35203746-E31D8C6B-B0EB-4CF9-9BC5-69B9E68904D6Q35879286-69FA9175-E3DB-4830-8726-5B5A6DAD305BQ35944750-68E11DE7-C1D7-411B-B8A1-93A128B56319Q36052362-3D1C21B0-8973-4C6D-87F9-1EF43BF6B56BQ36211388-E88444CB-0D40-4D60-81A1-19ABC87EBD9BQ36319508-E0CFCB51-9567-4DCF-AD6A-4F6177829B7DQ36465496-BAE01602-7A73-41B8-9CD0-DE7A8AB4C814Q36843548-8C07F83E-E5C2-4220-9A84-EB1048686D33Q37085580-4D195A24-771D-41FA-9511-607D5C3FE961Q37190412-A64F68A6-C8AA-45F6-A638-68998E556DAAQ37201777-A26B7B7A-FC15-45C1-ACA6-30C1DF694ADEQ37406308-12A0078E-C635-4B03-B947-7EF21745B360Q37735158-CAEF63E3-0F22-4FF1-A6C7-2B39C358C871Q37859419-EEB60EB4-5ED4-4CC5-AB5A-253BA02413ADQ37885457-FFAA6B9A-9857-4478-955F-4C9E07D32583Q37907433-500E3B1E-366B-4D56-AFB6-A9EFAC290AD2Q38230719-E1B5DB52-A214-4301-9A1E-6FED4D06B2FCQ38272635-8CD7780F-3FBA-4C0A-BDA8-85153A79B431
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Philip Newsome
@ast
Philip Newsome
@en
Philip Newsome
@es
Philip Newsome
@nl
Philip Newsome
@sl
Филипп Ньюсом
@ru
type
label
Philip Newsome
@ast
Philip Newsome
@en
Philip Newsome
@es
Philip Newsome
@nl
Philip Newsome
@sl
Филипп Ньюсом
@ru
prefLabel
Philip Newsome
@ast
Philip Newsome
@en
Philip Newsome
@es
Philip Newsome
@nl
Philip Newsome
@sl
Филипп Ньюсом
@ru
P214
P244
P1053
D-4495-2018
P106
P1153
56091606600
P21
P214
P244
n2013181346
P31
P3829
P496
0000-0001-6085-3652
P734
P735
P7859
lccn-n2013181346